Prudential Financial
AYTU icon

Prudential Financial’s AYTU BioPharma AYTU Stock Holding History

Prudential Financial’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,576
Closed -$31.3K – 2603
2023
Q2 		$31.3K Buy
19,576
+5,400
+38% +$10.6K ﹤0.01% 2579
2023
Q1 		$31.9K Buy
14,176
+5,198
+58% +$15.2K ﹤0.01% 2540
2022
Q4 		$33.9K Buy
8,978
+1,700
+23% +$6.4K ﹤0.01% 2530
2022
Q3 		$27K Buy
7,278
+5,240
+257% +$39.8K ﹤0.01% 2612
2022
Q2 		$28K Buy
+2,038
New +$26.1K ﹤0.01% 2626

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Prudential Financial's AYTU Position: Q3 2023 in Review

Prudential Financial sold out of AYTU BioPharma (AYTU) in Q3 2023, closing a stake of 19,576 shares — an estimated $31.3K sold.

Prudential Financial first reported a position in AYTU in Q2 2022 and held it in 5 quarters. The position peaked at $33.9K in Q4 2022. 22 funds tracked by Wall St. Rank hold AYTU as of Q3 2023.

  • Prudential Financial reported no remaining AYTU BioPharma position as of Q3 2023 after selling out during the quarter.
  • Prudential Financial sold 19,576 AYTU BioPharma shares in Q3 2023, an estimated $31.3K.
  • Prudential Financial first reported a position in AYTU BioPharma in Q2 2022 and held it in 5 quarters.
  • Prudential Financial's AYTU BioPharma position peaked at $33.9K in Q4 2022.
  • 22 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2023.

Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.